Pasithea Therapeutics (KTTA) Revenue & Revenue Breakdown
Pasithea Therapeutics Revenue Highlights
Pasithea Therapeutics Revenue by Period
Pasithea Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $486.56K | 3130.37% |
| 2021-12-31 | $15.06K | 100.00% |
| 2020-12-31 | - | - |
Pasithea Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Pasithea Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $976.31K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $240.71K | 10.11% |
| 2022-09-30 | $218.61K | 1509.66% |
| 2022-06-30 | $13.58K | -0.56% |
| 2022-03-31 | $13.66K | -9.32% |
| 2021-12-31 | $15.06K | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-09-30 | - | - |
Pasithea Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Pasithea Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KZR | Kezar Life Sciences | $7.00M | - |
| KRON | Kronos Bio | $6.29M | $2.69M |
| MNOV | MediciNova | $1.00M | - |
| ABVC | ABVC BioPharma | $152.43K | $117.14K |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| FBRX | Forte Biosciences | - | - |
| PXMD | PaxMedica | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| ELYM | Eliem Therapeutics | - | - |
| RNXT | RenovoRx | - | - |
| INDP | Indaptus Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| BWV | Onconetix | - | - |
| KTTA | Pasithea Therapeutics | - | - |
KTTA Revenue FAQ
What is Pasithea Therapeutics’s yearly revenue?
Pasithea Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $486.56K, representing an increase of 3130.37% compared to 2021. KTTA's yearly revenue for 2021 was $15.06K, representing an increase of 100.00% compared to 2020.
What is Pasithea Therapeutics’s quarterly revenue?
Pasithea Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $976.31K, a 100.00% increase from the previous quarter (Q3 2023), and a 305.59% increase year-over-year (Q4 2022). KTTA's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).
What is Pasithea Therapeutics’s revenue growth rate?
Pasithea Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%